These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 7518651)
1. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Aisen PS; Davis KL Am J Psychiatry; 1994 Aug; 151(8):1105-13. PubMed ID: 7518651 [TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction. Carter CJ Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244 [TBL] [Abstract][Full Text] [Related]
3. [The role of inflammatory reaction in Alzheimer's disease and neurodegenerative processes]. Członkowska A; Kurkowska-Jastrzebska I Neurol Neurochir Pol; 2002; 36(1):15-23. PubMed ID: 12053606 [TBL] [Abstract][Full Text] [Related]
5. [Inflammatory mechanisms in the pathogenesis of Alzheimer's disease]. Verbeek MM; Otte-Höller I; Ruiter DJ; de Waal RM Tijdschr Gerontol Geriatr; 1997 Oct; 28(5):213-8. PubMed ID: 9526791 [TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory drugs in the fight against Alzheimer's disease. McGeer PL; McGeer EG Ann N Y Acad Sci; 1996 Jan; 777():213-20. PubMed ID: 8624086 [TBL] [Abstract][Full Text] [Related]
7. Clinical aspects of inflammation in Alzheimer's disease. Rosenberg PB Int Rev Psychiatry; 2005 Dec; 17(6):503-14. PubMed ID: 16401549 [TBL] [Abstract][Full Text] [Related]
8. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease. Ozben T; Ozben S Clin Biochem; 2019 Oct; 72():87-89. PubMed ID: 30954437 [TBL] [Abstract][Full Text] [Related]
9. Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process. Eikelenboom P; Rozemuller JM; Kraal G; Stam FC; McBride PA; Bruce ME; Fraser H Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):329-36. PubMed ID: 1685040 [TBL] [Abstract][Full Text] [Related]
10. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Hardy J; Selkoe DJ Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773 [TBL] [Abstract][Full Text] [Related]
12. [Inflammation and Alzheimer's disease]. de Toledo M Rev Neurol; 2006 Apr 1-15; 42(7):433-8. PubMed ID: 16602061 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease. Uddin MS; Kabir MT; Mamun AA; Barreto GE; Rashid M; Perveen A; Ashraf GM Int Immunopharmacol; 2020 Jul; 84():106479. PubMed ID: 32353686 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. McGeer PL; Rogers J Neurology; 1992 Feb; 42(2):447-9. PubMed ID: 1736183 [TBL] [Abstract][Full Text] [Related]
15. Neuroinflammatory perspectives on the two faces of Alzheimer's disease. Eikelenboom P; van Gool WA J Neural Transm (Vienna); 2004 Mar; 111(3):281-94. PubMed ID: 14991455 [TBL] [Abstract][Full Text] [Related]
16. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Blasko I; Stampfer-Kountchev M; Robatscher P; Veerhuis R; Eikelenboom P; Grubeck-Loebenstein B Aging Cell; 2004 Aug; 3(4):169-76. PubMed ID: 15268750 [TBL] [Abstract][Full Text] [Related]